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The SREBP Pathway in Drosophila:
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and that the cleaved bHLH-zip domain is present in
nuclear extracts (Theopold et al., 1996). dSREBP was
expressed in all body regions of the fly and at all stages
Adam C. Seegmiller,2 Irina Dobrosotskaya,2
Joseph L. Goldstein,1 Y.K. Ho,
Michael S. Brown,1 and Robert B. Rawson
Department of Molecular Genetics of development. There was no information as to the
mechanism of cleavage of dSREBP, nor was there infor-University of Texas Southwestern Medical Center
Dallas, Texas 75390 mation about its pattern of regulation. In the only other
reported studies of dSREBP, Rosenfeld and Osborne
(1998) transfected a dSREBP fusion construct into mam-
malian cells and showed that the cleavage of dSREBPSummary
was inhibited by sterols. Studies of the regulated pro-
cessing of dSREBP in Drosophila cells have not beenIn mammals, synthesis of cholesterol and unsaturated
reported.fatty acids is controlled by SREBPs, a family of mem-
The finding of a dSREBP is somewhat surprising,brane-bound transcription factors. Here, we show that
since insects do not synthesize sterols (Clark and Bloch,the Drosophila genome encodes all components of the
1959). Insects possess the early enzymes in the sterolSREBP pathway, including a single SREBP (dSREBP),
biosynthetic pathway, which allows them to make a vari-SREBP cleavage-activating protein (dSCAP), and the
ety of isoprenoids, but they lack the enzymes necessarytwo proteases that process SREBP at sites 1 and 2 to
to convert farnesyl pyrophosphate to squalene and ste-release the nuclear fragment. In cultured Drosophila
rols. Insects require sterols for growth, but they obtainS2 cells, dSREBP is processed at sites 1 and 2, and
these sterols from their diet (Clark and Bloch, 1959).the liberated fragment increases mRNAs encoding en-
Since insects do not synthesize sterols, it seems unlikelyzymes of fatty acid biosynthesis, but not sterol or iso-
that sterols are the end products that regulate dSREBPprenoid biosynthesis. Processing requires dSCAP, but
cleavage in Drosophila cells.is not inhibited by sterols as in mammals. Instead,
The present studies were designed to determinedSREBP processing is blocked by palmitic acid. These
whether dSREBP cleavage in insect cells is carried outfindings suggest that the ancestral SREBP pathway
by the same type of proteolytic mechanism that is usedfunctions to maintain membrane integrity rather than
by mammalian cells and to determine whether this cleav-to control cholesterol homeostasis.
age is regulated by sterols or by some other lipid. We
studied this process in Schneider S2 cells, a line ofIntroduction
cultured cells derived from Drosophila embryos (Schnei-
der, 1972). The results reveal that dSREBP processingSterol regulatory element binding proteins (SREBPs)
is regulated not by sterols, but by palmitic acid or a lipidwere discovered in mammalian cells, where they stimu-
derived from palmitic acid. These findings suggest thatlate the synthesis of cholesterol (Wang et al., 1994; Yo-
SREBPs evolved to maintain the lipid composition ofkoyama et al., 1993) and unsaturated fatty acids (Kim
membranes and that their sterol regulatory function wasand Spiegelman, 1996; Shimano et al., 1996). The un-
acquired subsequent to a gene duplication event in theusual feature of these transcription factors is their initial
lineage leading from insects to vertebrates.location on cell membranes, from which they are re-
leased by proteolysis in order to enter the nucleus. Pro-
teolytic release of SREBPs is inhibited by sterols (Wang Results
et al., 1994) and polyunsaturated fatty acids (Hannah et
al., 2001; Thewke et al., 1998; Worgall et al., 1998), We began our studies by searching Drosophila DNA
sequence databases for genes encoding proteins re-thereby providing a mechanism for the feedback regula-
tion of lipid synthesis and membrane lipid composition lated to mammalian SREBPs and to the three proteins
known to be necessary for SREBP processing. Verte-(Brown and Goldstein, 1997).
Theopold et al. (1996) fortuitously isolated a Drosoph- brate organisms have genes encoding two isoforms
of SREBP, designated SREBP-1 and SREBP-2. Theila melanogaster cDNA encoding an apparent ortholog
to mammalian SREBPs. Like the mammalian proteins, SREBP-1 gene produces two transcripts, designated
SREBP-1a and SREBP-1c, that encode proteins withDrosophila SREBP contains an NH2-terminal transcrip-
tion factor domain of the basic-helix-loop-helix-leucine different NH2-terminal sequences owing to the use of
alternate promoters producing alternate first exonszipper (bHLH-zip) family, followed in order by a putative
membrane attachment domain with two transmembrane (Brown and Goldstein, 1997). Although the target genes
for these transcription factors overlap, SREBP-2 is rela-helices and by a long COOH-terminal extension. Using
antibodies raised against the bHLH-zip domain of hu- tively more selective for genes in the pathway of sterol
synthesis, whereas the SREBP-1 isoforms are more se-man SREBP-1, these investigators showed that the full-
length Drosophila SREBP is bound to cell membranes lective for production of unsaturated fatty acids (Horton
et al., 1998).
Figure 1A shows a hydropathy plot of the single1Correspondence: joe.goldstein@utsouthwestern.edu (J.L.G.),
dSREBP, as predicted by the cDNA sequence of Theo-mike.brown@utsouthwestern.edu (M.S.B.)
2 These authors contributed equally to this work. pold et al. (1996) and confirmed by us. The bHLH-zip
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Figure 1. Drosophila Orthologs of SREBP Pathway Components
Hydropathy plots of the amino acid sequences of components of the human SREBP pathway (upper panels) and their Drosophila counterparts
(lower panels) are shown, plotted by the method of Kyte and Doolittle (1982) over a window of 20 amino acids. The overall amino acid sequence
identities of the Drosophila proteins to their mammalian orthologs are hSREBP-1a, 26%; hSREBP-2, 23%; S1P, 42%; S2P, 26%; and SCAP,
24%. These values are calculated from pairwise alignments using the Clustal algorithm in the DNAStar software package (LaserGene). The
length of each sequence is indicated in amino acids (aa). Heavy bars denote regions of high sequence identity. For example, the percent
identity between hSREBP-1 and dSREBP in the bHLH zipper domain is 82% as compared to 80% identity between hSREBP-1 and hSREBP-2.
For S1P, the three residues comprising the catalytic triad are shown. For S2P, the sequences of the zinc binding motif and accessory ligand
are shown. For SCAP, the location of two point mutations in the sterol-sensing domain that produce a dominant, constitutively active phenotype
in CHO cells (Hua et al., 1996; Nohturfft et al., 1996) are shown. GenBank accession numbers are as follows: dSREBP (HLH106), U38238;
dSCAP, AF441759; dS1P, AF441758; and dS2P, AF441757.
domain of dSREBP closely resembles that of human dSREBP has two hydrophobic sequences correspond-
ing to the two transmembrane regions of the mammalianSREBP-1a (82% identity) and human SREBP-2 (66%
identity). Importantly, dSREBP contains the unique tyro- SREBPs, designated TM1 and TM2. The COOH-terminal
sequences of the three proteins are also similar. Ofsine residue that was shown to permit SREBPs to bind
to nonpalindromic target sequences (Kim et al., 1995). note, dSREBP has a relatively long acidic NH2-terminal
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Figure 2. Detection of dSREBP Protein in S2
Cells by Immunoblotting
On day 0, S2 cells were set up in medium A
as described in Experimental Procedures. On
day 2, cells were transfected in medium A
with 3 g/dish of either empty vector (lanes
1, 3, 5, and 7) or pDS47-HSV-dSREBP (lanes
2, 4, 6, and 8). After incubation in medium
A for 8 hr, the cells were washed and refed
medium C. After an additional 16 hr, cells
were harvested and fractionated into mem-
brane and nuclear extract fractions as de-
scribed in Experimental Procedures. Aliquots
of protein (10 g/lane) from transfected cells
were subjected to SDS-PAGE and immu-
noblot analysis with either 50 ng/ml of mono-
clonal anti-HSV (A) or 2 g/ml of monoclonal
anti-dSREBP (IgG-3B2; [B]). The filters were
exposed to film for 5 s. P and N denote the
precursor and nuclear cleaved forms of
dSREBP, respectively.
transcription-activating sequence, thereby resembling domain is 72% identical to that of human S1P, including
a putative catalytic triad (Asp-169, His-200, and Ser-365SREBP-2 and SREBP-1a in contrast to SREBP-1c,
which has a shorter sequence and is less active (Brown of dS1P). dS1P contains a second highly conserved
region that is 61% identical to hS1P. The protein alsoand Goldstein, 1997). dSREBP also contains the crucial
residues that are required for cleavage by the site 1 and shares a hydrophobic NH2-terminal signal sequence and
a COOH-terminal hydrophobic sequence that forms asite 2 proteases (S1P and S2P), which release the bHLH-
zip domain from the membrane (Brown and Goldstein, membrane anchor. Thus, the active site of dS1P, like
hS1P, should be located in the lumen of the ER and1999).
In mammalian cells, SREBPs form a complex with Golgi. The cytoplasmic COOH-terminal tail of dS1P, like
that of hS1P, is notable for its high concentration ofSCAP, a polytopic membrane protein that escorts
SREBPs from the ER to the Golgi complex where positively charged amino acids and the absence of neg-
atively charged residues. The intraluminal location ofSREBPs are cleaved (DeBose-Boyd et al., 1999; Sakai
et al., 1998a). The Drosophila genome encodes a protein the S1P active site is necessary because S1P cleaves
SREBPs in the luminal loop between the two transmem-that we have named dSCAP (Figure 1B). Like human
SCAP, the NH2 terminus of dSCAP is predicted to con- brane helices, thereby separating the NH2-terminal and
COOH-terminal halves of the SREBP, both of which re-tain eight membrane-spanning helices. Helices 2–6 in
the mammalian protein have been called the sterol- main membrane bound (Duncan et al., 1997).
The NH2-terminal product of S1P-mediated cleavagesensing domain (Brown and Goldstein, 1999). Similar
sequences are found in three other mammalian mem- is designated the “intermediate” fragment of SREBP
(Sakai et al., 1996). This intermediate is cleaved by S2Pbrane proteins (HMG CoA reductase, NPC1, and Patched).
In SCAP, this domain is postulated to sense the level at a site that is three residues within the transmembrane
helix (Duncan et al., 1998). This cleavage liberates theof cholesterol in the ER membrane and thereby to regu-
late the movement of the SCAP/SREBP complex from bHLH-zip domain, which enters the nucleus with three
hydrophobic residues at its COOH-terminus. hS2P is anER to Golgi. When sterols accumulate, the SCAP/SREBP
complex no longer leaves the ER, and SREBP pro- unusually hydrophobic zinc metalloprotease that con-
tains two sequences necessary for zinc binding andcessing is blocked (Nohturfft et al., 2000). Point muta-
tions at either of two residues in this domain (Tyr-298 catalysis. These are HEIGH (which fits the HEXXH con-
sensus for other zinc metalloproteases) and a COOH-or Asp-443) render hamster SCAP insensitive to sterols
(Nohturfft et al., 1998). As a result, SREBPs are pro- terminal LDG sequence (Brown et al., 2000). As shown
in Figure 1D, dS2P has corresponding HEMGH and FDGcessed constitutively, and the cells overaccumulate
massive amounts of cholesterol. Tyr-382 in dSCAP cor- sequences at the appropriate positions. dS2P also
shares a cysteine-rich region (ten cysteines), which isresponds to Tyr-298 in mammalian SCAP, but the posi-
tion corresponding to Asp-443 is occupied by an aspara- luminally disposed in hS2P (Zelenski et al., 1999).
To study the proteolytic processing of dSREBP, wegine in dSCAP (Asn-525). The COOH-terminal one-half
of human and hamster SCAP contains five copies of a prepared a cDNA encoding the Drosophila protein with
an NH2-terminal epitope tag derived from a herpes sim-WD-40 repeat sequence. In other proteins, these se-
quences form propeller structures that engage in pro- plex virus protein. After transfection into Drosophila S2
cells, immunoblotting with anti-HSV revealed the full-tein-protein interactions. The dSCAP sequence encodes
multiple WD repeats, as in mammalian SCAP. length dSREBP bound to cell membranes (designated
P for precursor form; Figure 2A, lane 2) and a proteolyzedAfter SREBPs arrive at the Golgi complex, they are
cleaved by S1P, a membrane-bound serine protease fragment corresponding to the mature form in nuclear
extracts (designated N for nuclear form; Figure 2A, lane(Sakai et al., 1998b). As shown in Figure 1C, the Drosoph-
ila genome encodes a putative protease whose catalytic 4). To visualize endogenous dSREBP, we prepared a
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monoclonal antibody against the NH2-terminal domain
of the protein and used it to blot membranes and nuclear
extracts from S2 cells. The antibody revealed a mem-
brane-bound protein (Figure 2B, lanes 5 and 6) and a
smaller nuclear protein (Figure 2B, lanes 7 and 8) that
corresponded in size to the precursor and nuclear forms
of the HSV-tagged dSREBP, respectively. This protein
was visualized in nontransfected cells (lanes 5 and 7) as
well as in cells expressing HSV-tagged dSREBP (lanes 6
and 8).
To determine the role of dSREBP in gene regulation,
we eliminated the dSREBP mRNA by treating the S2
cells with a double-stranded RNA fragment (dsRNA) cor-
responding to a region of the dSREBP transcript. Such
treatment, called RNAi (Clemens et al., 2000), leads to
the nucleolytic destruction of the endogenous mRNA.
As shown in Figure 3A, treatment with dSREBP dsRNA
caused the disappearance of the precursor and nuclear
forms of dSREBP as determined by immunoblotting of
the appropriate extracts. Treatment with a control dsRNA
directed against a control mammalian mRNA (CYP7A1)
had no effect on precursor or nuclear dSREBP.
We performed a series of Northern blots to measure
changes in mRNA levels for genes that are potential
targets of dSREBP in the cells treated with dSREBP
dsRNA (Figure 3B). As expected, the mRNA for dSREBP
Figure 3. RNAi-Mediated Inhibition of dSREBP Expression and Itswas no longer detectable. We also observed marked
Effects on Target Gene Expression in S2 Cellsreductions in mRNAs encoding acetyl CoA synthetase,
On day 0, S2 cells were suspended in medium B containing 50 gacetyl CoA carboxylase (ACC), and fatty acid synthase
of the indicated dsRNA per 106 cells and then plated as described
(FAS). Levels of these three mRNAs, which encode en- in Experimental Procedures.
zymes of fatty acid biosynthesis, decline in mammalian (A) Immunoblot analysis of dSREBP in membranes and nuclear ex-
cells when nuclear SREBPs decline (Luong et al., 2000; tracts. On day 2, cells were harvested, and aliquots of protein (20
and 15 g/lane, respectively) from the indicated cell fraction wereMatsuda et al., 2001). There was no change in two other
analyzed by immunoblotting with IgG-3B2. Film was exposed formRNAs that decline in SREBP-deficient mammalian
30 s. P and N denote the precursor and nuclear cleaved forms ofcells, namely, ATP-citrate lyase (an enzyme that gener-
dSREBP, respectively.
ates acetyl CoA to be used for lipid synthesis) and farne- (B) Northern blot analysis of target genes. Total RNA was isolated
syl diphosphate synthase (an enzyme of isoprenoid bio- from the cells in the same experiment as shown in (A), and aliquots
synthesis). As a control, we found no change in the (20 g) were analyzed by denaturing electrophoresis followed by
Northern blotting with the indicated probes. Filters were exposedmRNA encoding ribosomal protein 49 (RP49).
at 70C for 2–48 hr.To determine whether dSCAP is required for dSREBP
(C) Immunoblot analysis of dSREBP in whole-cell extracts. On daysprocessing, we incubated the cells with a dsRNA that
1, 2, and 3, fresh medium B containing 50 g of the indicated dsRNA
targets dSCAP. This treatment led to a complete disap- was added to each well. Cells were harvested on day 4 and lysed
pearance of the nuclear form of dSREBP and a marked in RIPA buffer (Gielkens et al., 1976) supplemented with 50 mM Tris-
reduction in the precursor form (Figure 3C). Similar re- HCl (pH 8.0), 2 mM MgCl2, and protease inhibitors (Hua et al., 1995).
Aliquots of total cell protein (40 g/lane) were analyzed by immu-sults are observed in mutant hamster cells that lack
noblotting with monoclonal IgG-3B2 against dSREBP. Film was ex-SCAP (Rawson et al., 1999).
posed for 40 s.Table 1 shows measurements of several mRNAs, as
determined by quantitative real-time PCR in S2 cells
treated with dsRNA targeting either dSREBP or dSCAP.
strongly regulated by SREBPs in mammalian liver (Shi-The level of each mRNA is expressed relative to the level
momura et al., 1998), but they did not decline in thefound in cells treated with the control dsRNA directed
dSREBP-deficient S2 cells. In mammalian liver, stearoylagainst mammalian CYP7A1. As expected, we observed
CoA desaturase is an important target of SREBPs,reductions in mRNAs encoding multiple enzymes of fatty
thereby providing a role for SREBPs in enhancing theacid biosynthesis, and these reductions were similar
synthesis of unsaturated fatty acids (Shimomura et al.,in the presence of the dSCAP or dSREBP dsRNAs. In
1998). However, in S2 cells, the stearoyl CoA desaturasecontrast, no change was observed in the expression of
ortholog did not change upon dSREBP deprivation.mRNAs encoding multiple enzymes in the mevalonate
Of note, we found a moderate decline of dSREBPpathway of isoprenoid biosynthesis, including 3-hydroxy-
mRNA in cells treated with dSCAP dsRNA (Table 1). This3-methylglutaryl CoA (HMG CoA) synthase, HMG CoA
suggests that dSREBP transcription may be regulatedreductase, and farnesyl diphosphate synthase, all of
by a positive feed-forward mechanism mediated by nu-which are prominent targets of SREBP in mammalian
clear dSREBP. The same phenomenon has been ob-cells (Matsuda et al., 2001). Malic enzyme and 6-phos-
served in mammalian cells (Matsuda et al., 2001; Raw-phogluconate dehydrogenase, which provide the re-
duced NADPH that is needed for lipid synthesis, are son et al., 1999). The modest increase in expression of
The SREBP Pathway in Drosophila
233
Table 1. Relative Amounts of mRNAs in Drosophila S2 Cells Treated with dsRNA Targeted against dSREBP or dSCAP
Relative mRNA Expression Level
mRNA dsSREBP dsSCAP
Reduced expression
Acetyl CoA synthase 0.24 0.43
Acetyl CoA carboxylase 0.38 0.41
Fatty acid synthase 0.15 0.17
Fatty acyl CoA synthetase 0.39 0.62
dSREBP * 0.66
No effect
Actin 0.98 1.00
ATP citrate lyase 0.93 0.90
Farnesyl diphosphate synthase 1.03 1.02
Glycerol-3-phosphate acyltransferase 0.98 0.75
Glycerol-3-phosphate dehydrogenase 0.98 1.07
3-Hydroxy-3-methylglutaryl CoA synthase 1.00 1.02
3-Hydroxy-3-methylglutaryl CoA reductase 0.94 0.91
Malic enzyme 1.00 0.91
6-Phosphogluconate dehydrogenase 0.88 0.82
Pyruvate dehydrogenase 0.99 0.86
SCAP 1.40 *
Site 1 protease 0.99 1.21
Site 2 protease 1.04 1.06
Stearoyl CoA desaturase 0.98 1.10
On day 0, cells were treated with the indicated dsRNA as described in the legend to Figure 3A (dsSREBP) or Figure 3C (dsSCAP). Total RNA
was extracted for analysis by real-time RT-PCR of the indicated mRNA. The values shown are relative to those in cells treated with control
CYP7A1 dsRNA, which were arbitrarily assigned a value of 1.0. All measurements were normalized to acetaldehyde dehydrogenase in the
same experiment. Each value shows the mean of triplicate measurements from the same pool of mRNA. Similar results were obtained in one
other independent experiment.
* The level of mRNA was not determined.
SCAP mRNA (1.4-fold) might also reflect a feedback (18:1), each of which constitutes about 20% of the total
fatty acid composition of the whole adult fly (De Reno-mechanism.
To confirm the functional effect of the reductions in bales and Blomquist, 1984). To determine whether one
of these fatty acids, palmitate, could regulate the pro-the mRNAs encoding fatty acid-synthesizing enzymes,
we treated S2 cells with dSREBP dsRNA, incubated cessing of dSREBP, we performed immunoblotting on
membranes and nuclear extracts of S2 cells using anthem with [14C]pyruvate, and measured the incorpora-
tion into [14C]fatty acids. [14C]Pyruvate was used instead antibody against the NH2-terminal domain of dSREBP
(Figure 4). When these cells were incubated with palmi-of [14C]acetate because pyruvate is converted into acetyl
CoA directly by the enzyme pyruvate dehydrogenase, tate, the amount of nuclear dSREBP declined dramati-
cally (Figure 4A). The effect of palmitate was detectablethereby avoiding the acetyl CoA synthetase step, which
is not considered to be a major step in normal fatty acid at 10M and maximal at 100 M (Figure 4B). In contrast,
a mixture of sterols (25-hydroxycholesterol plus choles-biosynthesis (Luong et al., 2000). As shown in Table 2,
we observed a 4-fold reduction in fatty acid synthesis terol), which is a potent suppressor of SREBP cleavage
in mammalian cells (Wang et al., 1994), failed to decreasein the cells treated with dSREBP dsRNA as compared
with the control CYP7A1 dsRNA. the nuclear form of dSREBP in S2 cells (Figure 4A).
In mammalian cells, sterols block SREBP processingThe above data indicate that dSREBP is required for
normal rates of synthesis of fatty acids in Drosophila S2 through specific inhibition of cleavage at site 1, which
lies within the luminal loop (Sakai et al., 1996). The trans-cells. The major fatty acids in the lipids of Drosophila
melanogaster are myristate (14 carbons, 0 double fection experiments of Figure 5 were designed to deter-
mine whether palmitate blocks cleavage of dSREBP atbonds), palmitate (16:0), palmitoleate (16:1), and oleate
Table 2. Incorporation of [14C]Pyruvate into Fatty Acids in S2 Cells Treated with dsRNA Targeted against dSREBP
Addition to medium Protein content [14C]Pyruvate → [14C]fatty acids
g/dish pmol/hr per mg protein
None 213  6 1035  97
dsCYP7A1 206  17 1320  97
dsSREBP 203  15 290  49
On day 0, S2 cells were suspended in medium B containing 50 g of the indicated dsRNA per 106 cells. Fresh medium B containing the
appropriate dsRNA was added on days 1 and 2. On day 3, sodium [2-14C]pyruvate was added directly to the culture medium at the final
concentration of 1.5 mM (2.8 dpm/pmol). The cells were incubated for 1 hr and harvested for measurement of total protein and [14C]fatty acid
content as described in Experimental Procedures. Each value represents the mean  SD of four incubations. Similar results were obtained
in four independent experiments.
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Figure 4. Proteolytic Processing of dSREBP in S2 Cells Is Regulated Figure 5. Palmitate Regulates Proteolytic Processing of dSREBP at
by Palmitate, but Not by Sterols Site 1
On day 0, S2 cells were set up in medium A as described in Experi- On day 0, S2 cells were set up in medium A as described in Experi-
mental Procedures. mental Procedures. On day 2, cells were transfected with 3g empty
(A) On day 2, cells were refed medium C containing either no addi- vector (lanes 1 and 2) or 100 ng of the indicated wild-type or mutant
tions, sterols (10 g/ml cholesterol plus 1 g/ml 25-hydroxycholes- version of pAC-HSV-dSREBP. In each case, the total amount of
terol), or 100 M sodium palmitate. All culture medium was adjusted transfected DNA in each dish was adjusted to 3 g with empty
to contain 0.2% (w/v) BSA and 0.2% (v/v) ethanol. vector. After 16 hr, the cells were washed and refed medium B
(B) On day 2, cells were refed medium C containing the indicated supplemented with either 0.2% BSA or 100 M sodium palmitate
concentration of sodium palmitate. All culture medium was adjusted (16:0). After an additional incubation for 4 hr (A) or 6 hr (B), cells
to contain 0.2% BSA. were harvested, and membrane and nuclear extract fractions were
(A and B) After incubation for 4 hr, cells were harvested, and mem- prepared as described in Experimental Procedures. Aliquots of pro-
brane and nuclear extract fractions were prepared as described in tein (2.5g/lane of membrane fraction; 15g/lane of nuclear extract)
Experimental Procedures. Aliquots of protein (2.5 g) were sub- were subjected to SDS-PAGE and immunoblot analysis with 50 ng/
jected to SDS-PAGE and immunoblot analysis with 2 g/ml mono- ml of monoclonal anti-HSV. The filters were exposed to film for either
clonal anti-dSREBP (IgG-3B2). The filters were exposed to film for 30 s (A) or 1 min (B).
either 10 s (A) or 1 min (B).
enter the nucleus. Next, we substituted phenylalanine-
leucine for an asparagine-proline sequence at positionthe same site. As shown in Figure 5A, when S2 cells were
transfected with a cDNA encoding full-length dSREBP, 462 in the transmembrane domain. The analogous sub-
stitution in mammalian SREBP prevents cleavage bypalmitate reduced the nuclear form (lane 4). There was
no reduction when the cells expressed a truncated form S2P (Ye et al., 2000). When the cDNA encoding this
mutant dSREBP was expressed in S2 cells, there wasof dSREBP that terminates prior to the membrane at-
tachment domain, and therefore does not require pro- no detectable nuclear form (lanes 7 and 8). Instead,
we observed a cleaved membrane-bound fragment thatteolytic cleavage in order to enter the nucleus (lanes 5
and 6). This experiment indicates that palmitate acts by corresponds to the intermediate created by cleavage at
site 1 (lane 7). The amount of this intermediate wasblocking cleavage of dSREBP and not by accelerating
degradation of the nuclear form. markedly reduced in the presence of palmitate (lane 8).
These results establish that palmitate in Drosophila cellsTo distinguish between cleavage at site 1 and site 2,
we transfected the S2 cells with cDNAs encoding mutant blocks cleavage of dSREBP at site 1.
The effect of palmitate was remarkably specific (Fig-forms of dSREBP with amino acid substitutions at sites
corresponding to the recognition sites for mammalian ure 6). The only other fatty acid that completely blocked
dSREBP cleavage in multiple experiments was theS1P and S2P (Figure 5B). When the S1P recognition site
was disrupted (R486A mutant; Duncan et al., 1997), the closely related (and unphysiological) 17-carbon satu-
rated fatty acid. Partial inhibitory effects were observedamount of nuclear dSREBP was markedly reduced in
the absence or presence of palmitate (Figure 5B, lanes for the 15-carbon and 18-carbon saturated fatty acids.
The introduction of even a single unsaturated bond re-5 and 6). This experiment indicates that dSREBP, like
mammalian SREBP, must be cleaved at site 1 in order to moved the ability of the 16-carbon fatty acid to suppress
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which thereby block SREBP processing (DeBose-Boyd
et al., 1999; Nohturfft et al., 2000). Sterol inhibition is
mediated through the membrane domain of SCAP,
which contains a polytopic membrane-spanning seg-
ment of 150 amino acids, termed the sterol-sensing
domain. Drosophila SCAP contains a sequence that
shares 47% identity with this sterol-sensing domain
(Figure 1B). In mammalian SCAP, sensitivity to sterols
is disrupted by one of two mutations; that is, when Tyr-
298 is mutated to Cys or when Asp-443 is mutated to
Asn (Nohturfft et al., 1998). In Drosophila SCAP, the
amino acid corresponding to Tyr-298 is Tyr-382, as de-
termined by sequence alignment. On the other hand,
the Drosophila equivalent of mammalian Asp-443, rather
than being an Asp, is Asn-525, which corresponds to
one of the two mutant versions of mammalian SCAP
that renders it sterol resistant. Whether this single amino
acid difference is the basis for the sterol resistance of
dSCAP remains to be determined.
Although the processing of dSREBP is not inhibited
by sterols, it is effectively blocked by palmitate, which
does not block processing in mammalian cells (Hannah
Figure 6. Palmitate, but Not Other Fatty Acids, Regulates Proteo- et al., 2001). If palmitate acts through the sterol-sensing
lytic Processing of dSREBP in S2 Cells
domain in dSCAP, this finding would suggest that this
On day 0, S2 cells were set up in medium A as described in Experi-
domain can respond to other lipids beside sterols. Per-mental Procedures. On day 2, cells were refed medium C containing
haps this domain senses some physical property of thethe indicated fatty acid at a final concentration of 100 M. All culture
ER membrane, such as membrane thickness or fluidity,medium was adjusted to contain 0.2% BSA. After incubation for 4
hr, cells were harvested, and membrane and nuclear extract frac- which in mammalian cells is altered by sterols and in
tions were prepared as described in Experimental Procedures. Ali- Drosophila cells by palmitate itself or, more likely, a lipid
quots of protein (2.5 g) were analyzed as described in Figure 2B. derived from palmitate.
The filters were exposed to film for 30 s ([A], membranes) or 2 Although palmitate and other saturated fatty acids do
min ([A and B], nuclear extracts; [B], membranes). P and N denote
not suppress SREBP cleavage in mammalian cells, weprecursor and nuclear cleaved forms of dSREBP, respectively.
and others have provided evidence that polyunsatu-
rated fatty acids, such as arachidonate, are capable of
achieving such suppression (Hannah et al., 2001;dSREBP cleavage (Figure 6B). We also tested a variety
Thewke et al., 1998; Worgall et al., 1998). Under certainof other compounds for their ability to decrease nuclear
conditions, these lipids act synergistically with sterols.dSREBP in Drosophila cells (see Supplemental Table
In experiments not shown, we found no additive effectS1 at http://www.developmentalcell.com/cgi/content/
when palmitate or other fatty acids were added to Dro-full/2/2/229/DC1). None of them had a significant effect.
sophila cells in combination with sterols. Whether ara-
chidonate in mammalian cells acts by the same mecha-
Discussion
nism as palmitate in Drosophila cells remains to be
determined.
The current data establish the following points regarding
In an evolutionary sense, the current data suggest
the SREBP pathway in Drosophila: (1) the Drosophila that the original function of the SREBP pathway may
genome contains one SREBP gene whose product re- have been to maintain the integrity of the cell membrane
sembles mammalian SREBP-1a and SREBP-2; (2) the by adjusting fatty acid synthesis in response to an ex-
Drosophila genome encodes orthologs of mammalian cess or deficiency of palmitic acid or a lipid derived
SCAP, S1P, and S2P; (3) dSREBP is processed at site from palmitic acid. During evolution, the single ancestral
1 and site 2 in a process that requires dSCAP, thereby SREBP gene became duplicated in the lineage leading
generating an NH2-terminal nuclear fragment; (4) nuclear to vertebrates, and the resulting mammalian SREBP pro-
dSREBP enhances transcription of genes encoding en- teins acquired additional roles in regulating cholesterol
zymes of fatty acid biosynthesis, but not cholesterol or homeostasis and in mediating increased lipid synthesis
isoprenoid biosynthesis; and (5) processing of dSREBP in liver in response to insulin (Matsuda et al., 2001).
at site 1 is decreased in the presence of palmitate, but Further evolutionary insights will require the identifica-
not other fatty acids or sterols. It is not yet clear whether tion of the palmitate-derived lipid that regulates the pro-
palmitate itself inhibits processing of dSREBP or cessing of dSREBP.
whether palmitate must be incorporated into a more
complex lipid, such as a sphingolipid or a glyceryl phos- Experimental Procedures
pholipid, to exert its regulatory effect.
MaterialsThe studies in Drosophila cells provide interesting
We obtained affinity-purified donkey anti-mouse IgG from Jacksonsimilarities and contrasts with the SREBP pathway in
Immunoresearch Laboratories; monoclonal antibody IgG-HSV-
mammalian cells. In mammalian cells, SCAP transports TagTM from Novagen; free fatty acids from Sigma-Aldrich; N-acetyl-
SREBPs from the ER to the Golgi apparatus where S1P leucinal-leucinal-norleucinal (ALLN) from CalBiochem; defatted bo-
vine serum albumin (BSA) from Boehringer Mannheim; vectorsand S2P reside. This transport is inhibited by sterols,
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pDS47/V5-HisA and pAc5.1/V5-HisB, Drosophila S2 cells, and a using the QuickChange Site-Directed Mutagenesis kit (Stratagene).
Plasmids were sequenced to confirm the mutations.calcium phosphate transfection kit from Invitrogen; and [2-14C]pyru-
vic acid, sodium salt (5.5 mCi/mmol) from American Radiolabeled
Chemicals. Delipidated fetal calf serum and BSA-bound fatty acids
Antibodies
were prepared as described previously (Hannah et al., 2001).
pGST-dSREBP(1–451) encodes the first 451 amino acids of dSREBP
fused to glutathione-S-transferase in a pGEX-4T-1 bacterial expres-
cDNA Cloning sion vector (Novagen). The insert was generated by PCR using the
Computer-based searches of the Berkeley Drosophila Genome Proj- following primers, which incorporate an EcoR1 site (underlined) and
ect (BDGP) databases using mammalian protein sequences identi- Xho1 site (underlined) preceded by an in-frame stop codon (bold)
fied partial genomic sequences for potential orthologs of SCAP and to facilitate directional cloning: 5-GGAATTCGACACGACACTGAT
S1P. These sequences were used to design primers for PCR using GAACTTAATAGACGC-3 and 5-CTAGCTCGAGCTAGAGTCCGAG
fly genomic DNA as a template (dSCAP: 5-GCTGAGCTGCACCCA GCGAGAGTGGGTGGC-3. Monoclonal antibody IgG-3B2 against
AGGGGCTGG-3, 5-GTTCAAGGGTTGCCGTCATTGTGCC-3; dS1P: dSREBP was produced by immunizing a mouse (Herz et al., 1990)
5-AACATTTTTGAGCAGGGAGCTGG-3, 5-CTGACATCCAACCGG with a fusion protein produced by expressing pGST-dSREBP(1–451)
TCCACGGCC-3). The amplified fragments were used to screen in E. coli. IgG1 fractions of antibody were purified by protein
several Drosophila cDNA libraries (Tom Kornberg, University of Cali- G-Sepharose.
fornia, San Francisco; LD cDNA library from BDGP). Inserts from
purified clones were sequenced in their entirety from both strands.
S2 CellsFor SCAP, 5 RACE with reverse transcription at 65C was used to
Stock cultures of Drosophila S2 cells were continuously grown inrecover the complete sequence since none of the clones extended
medium A (Schneider’s Drosophila medium [Life Technologies] sup-to the 5 end of the transcript. Searches with human S2P identified
plemented with 10% heat-inactivated fetal calf serum, 100 units/mlseveral Drosophila EST clones encoding sequences that resembled
penicillin, and 100 g/ml streptomycin sulfate) at 23C. Cells weredifferent portions of the human cDNA. Two clones from the same
set up for experiments on day 0 in either medium A or mediumcDNA library were obtained from the BDGP (LD14421 and LD11632).
B (Ultimate Insect Serum-Free medium [Invitrogen]) as describedSequencing of their inserts showed that each encoded the complete
below.coding sequence of dS2P.
Expression Plasmids Proteolytic Processing of dSREBP
pAc-HSV-dSREBP encodes full-length Drosophila SREBP (amino Cells were set up for experiments in medium A at a density of 1 
acids 2–1113) fused at its NH2 terminus with two tandem copies of 106 cells per 60 mm dish. On day 2, the cells were refed medium C
the HSV epitope tag (QPELAPEDPED; Isola et al., 1989) under the (IPL-41 Insect medium [Life Technologies] supplemented with 10%
control of the Drosophila actin 5C promoter. This plasmid was con- heat-inactivated delipidated fetal calf serum, 100 units/ml penicillin,
structed by simultaneous ligation of three DNA fragments: (1) a 5.3 and 100 g/ml streptomycin sulfate) in the absence or presence
kb fragment generated by digestion of the expression vector pAc5.1/ of BSA-bound fatty acids (Hannah et al., 2001; at the indicated
V5-HisB with EcoRI and XbaI; (2) a 3.3 kb fragment including the concentration) or sterols (10 g/ml cholesterol plus 1 g/ml 25-
entire dSREBP coding sequence (amino acids 2–1113) generated hydroxycholesterol added in a final concentration of 0.2% [v/v] etha-
by PCR from a plasmid carrying dSREBP cDNA (obtained from nol). Cells were incubated for 3 hr followed by the direct addition
D. Hultmark, Stockholm University, Stockholm, Sweden; previously of ALLN (3 l into 3 ml of medium) to achieve a final concentration
referred to as HLH106; Theopold et al., 1996) using primers 5- of 25 g/ml. One hour later the cells were harvested by scraping
GAAGATATCGATGACACGACACTGATGAACTTAATAG-3 and 5- into the medium, and the cell suspension from duplicate dishes was
TTCATCTCTAGACTATCCTAAGCCTTCACGCTGCCAA-3, followed combined. Cells were homogenized and fractionated as described
by restriction digestion with BspDI and XbaI to cleave sites at the previously to yield membrane and nuclear extract fractions (Sakai
ends of each primer (underlined); and (3) a 179 bp fragment including et al., 1996).
a start codon and two copies of the HSV epitope tag generated by
PCR from another HSV-tagged expression plasmid using primers
Transfection of S2 Cells5-GATGCAGAATTCAGCCATGCAGCCTGAACTCGCTCCA-3 and
Cells were set up on day 0 in medium A at a density of 1  106 cells5-CGTGTCATCGATATCTTCCGGATCCTCTGG-3, followed by re-
per 60 mm dish. On day 1, the cells were transfected with a calciumstriction digestion with EcoRI and BspDI to cleave sites at the ends
phosphate transfection kit (Invitrogen) in medium A according to theof each primer (underlined).
manufacturer’s instructions. Cells were incubated with the plasmidpAc-HSV-dSREBP(1–451) encodes the NH2-terminal cytosolic do-
DNA/calcium phosphate precipitate for either 8 or 16 hr, after whichmain of dSREBP (amino acids 1–451) with an NH2-terminal HSV
the cells were washed twice with medium A without serum and refedepitope tag under control of the Drosophila actin 5C promoter. This
with medium C as described in the figure legends.plasmid was constructed in the same manner as pAc-HSV-dSREBP,
except that the 3.3 kb dSREBP fragment was replaced with a 1.4
kb fragment including codons 2–451 of dSREBP followed by a stop SDS-PAGE and Immunoblot Analysis
codon. This fragment was generated by PCR from the dSREBP Protein concentrations in membrane and nuclear extract fractions
cDNA plasmid described above using primers 5-GAAGATATCGAT were measured using a BCA kit (Pierce). Prior to SDS-PAGE, the
GACACGACACTGATGAACTTAATAG-3 and 5-TTCTAGTCTAGAT membrane and nuclear extract fractions were mixed with 0.25 vol-
CAGAGTCCGAGGCGAGAGTGGGTGG-3. The PCR product was di- ume of 5 SDS loading buffer (1 loading buffer contains 30 mM
gested with BspDI and XbaI (underlined) and simultaneously ligated Tris-HCl [pH 7.4], 3% [w/v] SDS, 5% [v/v] glycerol, 0.004% [w/v]
to the pAc5.1 vector and HSV tag fragments described above. bromphenol blue, and 2.5% [v/v] -mercaptoethanol). Aliquots of
pDS47-HSV-dSREBP encodes full-length Drosophila SREBP the fractions were boiled for 5 min, subjected to SDS-PAGE on 8%
(amino acids 2–1113) fused at its NH2 terminus with two tandem polyacrylamide gels, and transferred to Hybond-C extra nitrocellu-
copies of the HSV epitope tag under the control of the Drosophila lose filters (Amersham Life Science). The filters were blocked with
DS47 promoter. This plasmid was constructed as follows: pAc-HSV- a solution of 5% (w/v) nonfat dry milk and 5% (v/v) newborn calf
dSREBP described above was digested with EcoRI and XbaI to serum in PBS-Tween (Sigma-Aldrich), and then incubated with the
liberate the entire coding region of HSV-dSREBP. This fragment was antibodies listed in the figure legends. After washing, bound anti-
ligated to EcoRI/XbaI-digested pDS47/V5-HisA empty expression bodies were visualized with peroxidase-conjugated donkey anti-
vector. mouse IgG using the SuperSignal CL-HRP substrate system (Pierce)
as previously described (Sakai et al., 1996). Gels were calibrated
with broad range prestained molecular weight markers (Bio-Rad).Site-Directed Mutagenesis
Plasmids pAc-HSV-dSREBP(R486→ A) and pAc-HSV-dSREBP(N462P→ Filters were exposed to Kodak X-Omat Blue XB-1 film (NEN Life
Science Products) at room temperature for the indicated time.FL) were created by site-directed mutagenesis of pAc-HSV-dSREBP
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dsRNA Production and RNAi American Heart Association (0130010N), the Perot Family Founda-
tion, and the W.M. Keck Foundation. A.C.S. is supported by NIHDNA templates for the synthesis of double-stranded RNA (dsRNA)
were generated by PCR and purified using the High Pure PCR Prod- Medical Scientist Training grant GM08014.
uct Purification kit (Boehringer Mannheim). Primer sequences are
shown in Supplemental Table S2A. dsRNA was synthesized using Received November 2, 2001; revised December 4, 2001.
a MEGAscript T7 kit (Ambion) as described (Clemens et al., 2000;
http://dixonlab.biochem.med.umich.edu/protocols/). The dsRNA frag- References
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